CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-02 | Vasista Vittal Chief Financial Officer | Exercise or conversion | +20,833 | $19.50 | $406K | 191,024 |
| 2018-11-02 | Vasista Vittal Chief Financial Officer | Sale | −53,741 | $70.26 | $3.8M | 137,283 |
| 2018-11-02 | Vasista Vittal Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −32,908 | 32,374 | ||
| 2018-11-02 | Vasista Vittal Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −20,833 | 29,167 | ||
| 2018-11-01 | Vasista Vittal Chief Financial Officer | Exercise or conversion | +9,959 | $3.76 | $37K | 147,242 |
| 2018-11-01 | Vasista Vittal Chief Financial Officer | Exercise or conversion | +9,718 | $13.09 | $127K | 156,960 |
| 2018-11-01 | Vasista Vittal Chief Financial Officer | Sale | −19,677 | $70.04 | $1.4M | 137,283 |
| 2018-11-01 | Vasista Vittal Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −9,959 | 20,041 | ||
| 2018-11-01 | Vasista Vittal Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −9,718 | 65,282 | ||
| 2018-10-29 | Yoo Stephen Chief Medical Officer | Exercise or conversion | +20,414 | $0.85 | $17K | 20,414 |
| 2018-10-29 | Yoo Stephen Chief Medical Officer | Sale | −3,042 | $59.83 | $182K | 17,372 |
| 2018-10-29 | Yoo Stephen Chief Medical Officer | Sale | −1,700 | $60.66 | $103K | 15,672 |
| 2018-10-29 | Yoo Stephen Chief Medical Officer | Sale | −2,100 | $61.82 | $130K | 13,572 |
| 2018-10-29 | Yoo Stephen Chief Medical Officer | Sale | −8,026 | $62.93 | $505K | 5,546 |
| 2018-10-29 | Yoo Stephen Chief Medical Officer | Sale | −5,446 | $63.67 | $347K | 100 |
| 2018-10-29 | Yoo Stephen Chief Medical Officer | Sale | −100 | $64.42 | $6K | 0 |
| 2018-10-29 | Yoo Stephen Chief Medical Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −20,414 | 102,072 | ||
| 2018-10-18 | Christmas Patrick J. SVP, General Counsel | Exercise or conversion | +5,000 | $12.10 | $61K | 22,669 |
| 2018-10-18 | Christmas Patrick J. SVP, General Counsel | Sale | −1,500 | $61.22 | $92K | 21,169 |
| 2018-10-18 | Christmas Patrick J. SVP, General Counsel | Sale | −3,410 | $62.00 | $211K | 17,759 |
Page 36 of 43 · 852 trades